Endoscopic management of hilar cholangiocarcinoma

Nature Reviews Gastroenterology and Hepatology

Volumn 9, Issue 2, 2012, Pages 105-112

  Parodi, Andrea ^a   Fisher, Deborah ^b   Giovannini, Marc ^c   Baron, Todd ^d   Conio, Massimo ^a  

^a Department of Gastroenterology   (Italy)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c INSTITUT PAOLI CALMETTES   (France)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPIRATION BIOPSY; BILE DUCT BYPASS; BILE DUCT CARCINOMA; BILIARY TRACT ENDOSCOPY; BRACHYTHERAPY; CANCER PALLIATIVE THERAPY; CANCER STAGING; CHOLANGITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFOCAL LASER MICROSCOPY; CYTOLOGY; DIAGNOSTIC ACCURACY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC THERAPY; EXTERNAL BEAM RADIOTHERAPY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; OBSTRUCTIVE JAUNDICE; PERCUTANEOUS DRAINAGE; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; PHOTODYNAMIC THERAPY; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; STENT; TUMOR BIOPSY;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DISEASE MANAGEMENT; ENDOSCOPY; ENDOSONOGRAPHY; HUMANS;

EID: 84856969559     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2011.271     Document Type: Review

References (76)

1. Khan, S. A. et al. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J. Hepatol. 37, 806-813 (2002). (Pubitemid 35404220)
2. Shaib, Y. & El-Serag, H. B. The epidemiology of cholangiocarcinoma. Semin. Liver Dis. 24, 115-125 (2004). (Pubitemid 38738341)
3. Khan, S. A., Thomas, H. C., Davidson, B. R. & Taylor-Robinson, S. D. Cholangiocarcinoma. Lancet 366, 1303-1314 (2005). (Pubitemid 41416587)
4. Watanapa, P. & Watanapa, W. B. Liver fluke-associated cholangiocarcinoma. Br. J. Surg. 89, 962-970 (2002). (Pubitemid 34994687)
5. Shaib, Y. H. et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am. J. Gastroenterol. 102, 1016-1021 (2007). (Pubitemid 46698225)
6. Walker, N. J. et al. Dose-additive carcinogenicity of a defined mixture of "dioxin-like compounds". Environ. Health Perspect. 113, 43-48 (2005).
7. Welzel, T. M., McGlynn K. A., Hsing, A. W., O'Brien, T. R. & Pfeiffer, R. M. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J. Natl Cancer Inst. 21, 873-875 (2006). (Pubitemid 43923444)
8. Nimura, Y., Hayakawa, N., Kamiya, J., Kondo, S. & Shionoya, S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J. Surg. 14, 535-543 (1990). (Pubitemid 20272534)
9. Wetter, L. A., Ring, E. J., Pellegrini, C. A. & Way, L. W. Differential diagnosis of sclerosing cholangiocarcinomas of the common hepatic duct (Klatskin tumors). Am. J. Surg. 161, 57-62 (1991).
10. Jarnagin, W. R. et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann. Surg. 234, 507-517 (2001).
11. Sobin, L. H., Gospodarowicz, M. K. & Wittekind, C. in TNM Classification of Malignant Tumours, 7th edn, 122-125 (Wiley-Blackwell, Oxford, 2009).
12. Bismuth, H. & Corlette, M. B. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg. Gynecol. Obstet. 140, 170-178 (1975).
13. Lee, H. Y. et al. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology 239, 113-121 (2006).
14. Chen, H. W. et al. Preoperative evaluation of resectability of Klatskin tumor with 16-slice MDCT angiography and cholangiography. AJR Am. J. Roentgenol. 186, 1580-1586 (2006). (Pubitemid 46112520)
15. Park, H. S. et al. Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography versus MDCT with direct cholangiography. AJR Am. J. Roentgenol. 190, 396-405 (2008).
16. Baron, T. H. et al. The role of endoscopy in the evaluation and treatment of patients with pancreaticobiliary malignancy. Gastrointest. Endosc. 58, 643-649 (2003).
17. de Bellis, M. et al. Influence of stricture dilation and repeat brushing on the cancer detection rate of brush cytology in the evaluation of malignant biliary obstruction. Gastrointest. Endosc. 58, 176-182 (2003). (Pubitemid 38220264)
18. Weber, A. et al. Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma. World J. Gastroenterol. 14, 1097-1101 (2008). (Pubitemid 351325011)
19. Bergquist, A., Tribukait, B., Glaumann, H. & Broome, U. Can DNA cytometry be used for evaluation of malignancy and premalignancy in bile duct strictures in primary sclerosing cholangitis? J. Hepatol. 33, 873-877 (2000).
20. Moreno Luna, L. E. et al. Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures. Gastroenterology 131, 1064-1072 (2006). (Pubitemid 44498705)
21. Bangarulingam, S. Y. et al. Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis. Hepatology 51, 174-180 (2010).
22. Fritscher-Ravens, A. et al. EUS-guided fine-needle aspiration cytodiagnosis of hilar cholangiocarcinoma: a case series. Gastrointest. Endosc. 52, 534-540 (2000).
23. Rösch, T. et al. ERCP or EUS for tissue diagnosis of biliary strictures? A prospective comparative study. Gastrointest. Endosc. 60, 390-396 (2004). (Pubitemid 39164248)
24. Lee, J. H., Salem, R., Aslanian, H., Chacho, M. & Topazian, M. Endoscopic ultrasound and fine-needle aspiration of unexplained bile duct strictures. Am. J. Gastroenterol. 99, 1069-1073 (2004). (Pubitemid 38917810)
25. Eloubeidi, M. A. et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of suspected cholangiocarcinoma. Clin. Gastroenterol. Hepatol. 2, 209-213 (2004). (Pubitemid 38293307)
26. Fritscher-Ravens, A. et al. EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology. Am. J. Gastroenterol. 99, 45-51 (2004). (Pubitemid 38679100)
27. Byrne, M. F. et al. Yield of endoscopic ultrasound-guided fine-needle aspiration of bile duct lesions. Endoscopy 36, 715-719 (2004). (Pubitemid 39149415)
28. DeWitt, J., Misra, V. L., Leblanc, J. K., McHenry, L. & Sherman, S. EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results. Gastrointest. Endosc. 64, 325-333 (2006). (Pubitemid 44233562)
29. Gleeson, F. C. et al. EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest. Endosc. 67, 438-443 (2008). (Pubitemid 351260042)
30. Gores, G. J. Early detection and treatment of cholangiocarcinoma. Liver Transpl. 6 (Suppl. 2), S30-S34 (2000).
31. Giovannini, M. et al. Endoscopic ultrasound elastography for evaluation of lymph nodes and pancreatic masses: a prospective multicenter study. World J. Gastroenterol. 7, 1587-1593 (2009).
32. Mentzel. J., Poremba, C., Dietl, K. H. & Domschke, W. Preoperative diagnosis of bile duct strictures-comparison of intraductal ultrasonography with conventional endosonography. Scand. J. Gastroenterol. 35, 77-82 (2000). (Pubitemid 30066776)
33. Stavaropoulos, S., Larghi, A., Verna, E., Battezzati, P. & Stevens, P. Intraductal ultrasound for the evaluation of patients with biliary strictures and no abdominal mass on computed tomography. Endoscopy 37, 715-721 (2005). (Pubitemid 41078903)
34. Domagk, D. et al. Endoscopic retrograde cholangiopancreatography, intraductal ultrasonography, and magnetic resonance cholangiopancreatography in bile duct strictures: a prospective comparison of imaging diagnostics with histopathological correlation. Am. J. Gastroenterol. 99, 1684-1689 (2004). (Pubitemid 39237492)
35. Kim, H. M. et al. Intraductal ultrasonography combined with percutaneous transhepatic cholangioscopy for the preoperative evaluation of longitudinal tumor extent in hilar cholangiocarcinoma. J. Gastroenterol. Hepatol. 25, 286-292 (2010).
36. Giovannini, M. et al. Results of a phase I-II study on intraductal confocal microscopy (IDCM) in patients with common bile duct (CBD) stenosis. Surg. Endosc. 25, 2247-2253 (2011).
37. Sakamoto, E. et al. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann. Surg. 227, 405-411 (1998). (Pubitemid 28131022)
38. Itoi, T. et al. Peroral cholangioscopic diagnosis of biliary-tract diseases by using narrow-band imaging (with videos). Gastrointest. Endosc. 66, 730-736 (2007). (Pubitemid 47464250)
39. Tischendorf, J. W. et al. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Endoscopy 38, 665-669 (2006).
40. Chen, Y. K. & Pleskow, D. K. SpyGlass single-operator peroral cholangiopancreatoscopy system for the diagnosis and therapy of bile-duct disorders: a clinical feasibility study (with video). Gastrointest. Endosc. 65, 832-841 (2007). (Pubitemid 46629073)
41. Smith, A. C., Dowsett, J. F., Russell, R. C., Hatfield, A. R. & Cotton PB. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 17, 1655-1660 (1994). (Pubitemid 24371094)
42. Pinol, V. et al. Percutaneous self-expanding metal stents versus endoscopic polyethylene endoprostheses for treating malignant biliary obstruction: randomized clinical trial. Radiology 225, 27-34 (2002).
43. Speer, A. G. et al. Randomized trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet 11, 57-62 (1987). (Pubitemid 17090508)
44. Paik, W. H. et al. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Gastrointest. Endosc. 69, 55-62 (2009).
45. Giovannini, M. et al. Hepaticogastrostomy by echo-endoscopy as a palliative treatment in a patient with metastatic biliary obstruction. Endoscopy 35, 1076-1078 (2003). (Pubitemid 37493034)
46. Park, H. et al. EUS-guided hepaticogastrostomy with a fully covered metal stent as the biliary diversion technique for an occluded biliary metal stent after a failed ERCP (with videos).Gastrointest. Endosc. 71, 413-419 (2010).
47. De Palma, G. D., Galloro, G., Siciliano, S., Iovino, P. & Catanzano, C. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest. Endosc. 53, 547-553 (2001). (Pubitemid 33587025)
48. Naitoh, I. et al. Unilateral versus bilateral endoscopic metal stenting for malignant hilar biliary obstruction. J. Gastroenterol. Hepatol. 24, 552-557 (2009).
49. Vienne, A. et al. Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment. Gastrointest. Endosc. 72, 728-735 (2010).
50. Kennedy, T. J. et al. Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford) 11, 445-451 (2009).
51. Kaassis, M. et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest. Endosc. 57, 178-182 (2003). (Pubitemid 36236755)
52. Levy, M. J., Baron, T. H., Gostout, C. J., Petersen, B. T. & Farnell, M. B. Palliation of malignant extrahepatic biliary obstruction with plastic versus expandable metal stents: an evidence-based approach. Clin. Gastroenterol. Hepatol. 2, 273-285 (2004). (Pubitemid 38447190)
53. Soderlund, C. & Linder, S. Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest. Endosc. 63, 986-995 (2006). (Pubitemid 43776145)
54. Wagner, H. J., Knyrim, K., Vakil, N. & Klose, K. J. Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. A prospective and randomized trial. Endoscopy 25, 213-218 (1993). (Pubitemid 23133215)
55. Perdue, D. G. et al. Plastic versus self-expanding metallic stents for malignant hilar biliary obstruction: a prospective multicenter observational cohort study. J. Clin. Gastroenterol. 42, 1040-1046 (2008).
56. De Palma, G. et al. Unilateral placement of metallic stents for malignant hilar obstruction: a prospective study. Gastrointest. Endosc. 58, 50-53 (2003). (Pubitemid 38208746)
57. Singh, V., Singh, G., Verma, G. R., Singh, K. & Gulati, M. Contrast free unilateral endoscopic palliation in malignant hilar biliary obstruction: new method. J. Gastroenterol. Hepatol. 19, 589-592 (2004). (Pubitemid 38669909)
58. Dumas, R. et al. Endoscopic bilateral metal stent placement for malignant hilar stenoses: identification of optimal technique. Gastrointest. Endosc. 51, 334-338 (2000). (Pubitemid 30149229)
59. Shinchi, H., Takao, S., Nishida, H. & Aikou, T. Length and quality of survival following external beam radiotherapy combined with expandable metallic stent for unresectable hilar cholangiocarcinoma. J. Surg. Oncol. 75, 89-94 (2000).
60. Cheng, J. L. et al. Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents. Gastrointest. Endosc. 56, 33-39 (2002). (Pubitemid 41115046)
61. Kawamoto, H. et al. Endoscopic deployment of multiple JOSTENT SelfX is effective and safe in treatment of malignant hilar biliary strictures. Clin. Gastroenterol. Hepatol. 6, 401-408 (2008).
62. Chennat, J. & Waxman, I. Initial performance profile of a new 6F self-expanding metal stent for palliation of malignant hilar biliary obstruction. Gastrointest. Endosc. 72, 632-636 (2010).
63. Raju, R. P. et al. Optimum palliation of inoperable hilar cholangiocarcinoma: comparative assessment of the efficacy of plastic and self-expanding metal stents. Dig. Dis. Sci. 56, 1557-1564 (2011).
64. Peters, R. A., Williams, S. G. J., Lombard, M., Karani, J. & Westaby, D. The management of high-grade hilar strictures by endoscopic insertion of self-expanding metal endoprostheses. Endoscopy 28, 10-16 (1997). (Pubitemid 27116855)
65. Freeman M. L. & Overby, C. Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents. Gastrointest. Endosc. 58, 41-49 (2003). (Pubitemid 38208745)
66. Hintze, R. E. et al. Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors. Gastrointest. Endosc. 53, 40-46 (2001). (Pubitemid 32109448)
67. Polydorou, A. A. et al. Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion. Gut 32, 685-689 (1991).
68. Rerknimitr, R., Kladcharoen, N., Mahachai, V. & Kullavanijaya, P. Result of endoscopic biliary drainage in hilar cholangiocarcinoma. J. Clin. Gastroenterol. 38, 518-523 (2004). (Pubitemid 38808426)
69. Singh, V., Singh, G., Gupta, V., Gupta, R. & Kapoor, R. Contrast-free air cholangiography-assisted unilateral plastic stenting in malignant hilar biliary obstruction. Hepatobiliary Pancreat. Dis. Int. 9, 88-92 (2010).
70. Ortner, M. E. et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 125, 1355-1363 (2003). (Pubitemid 37409755)
71. Zoepf, T., Jakobs, R., Arnold, J. C., Apel, D. & Riemann, J. F. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am. J. Gastroenterol. 100, 2426-2430 (2005).
72. Gerhardt, T. et al. Combination of bilateral metal stenting and trans-stent photodynamic therapy for palliative treatment of hilar cholangiocarcinoma. Z. Gastroenterol. 48, 28-32 (2010).
73. Witzigmann, H. et al. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to R1/R2 resection. Ann. Surg. 244, 230-239 (2006). (Pubitemid 44305537)
74. Quyn, A. J., Ziyaie, D., Polignano, F. M. & Tait, I. S. Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinoma. HPB (Oxford) 11, 570-577 (2009).
75. Fletcher, M. S., Brinkley, D., Dawson, J. L., Nunnerley, H. & Williams, R. Treatment of hilar carcinoma by bile drainage combined with internal radiotherapy using 192iridium wire. Br. J. Surg. 70, 733-735 (1983). (Pubitemid 14248371)
76. Kuvshinoff, B. W. et al. Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy. Br. J. Surg. 82, 1522-1525 (1995).